Related Experiment Video

Updated: Jul 7, 2026

4D Imaging of Protein Aggregation in Live Cells
08:59

4D Imaging of Protein Aggregation in Live Cells

Published on: April 5, 2013

Combating protein misfolding and aggregation by intracellular antibodies

Alessio Cardinale1, Silvia Biocca

  • 1IRCCS San Raffaele, Roma, Italy.

Current Molecular Medicine
|February 22, 2008
PubMed

Insights

Intrabodies offer a promising therapeutic strategy for protein misfolding diseases by targeting and neutralizing misfolded protein aggregates. Advances in recombinant antibody technology enhance their specificity and stability for clinical applications.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Immunology

Background:

  • Protein misfolding and aggregation cause devastating conformational diseases.
  • Genetic and environmental factors, including aging, contribute to these disorders.
  • Current treatments for conformational diseases are limited, with growing clinical relevance.

Purpose of the Study:

  • To review the therapeutic potential of intrabodies for treating protein misfolding diseases.
  • To evaluate the various mechanisms of action of intrabodies in preventing protein aggregation.
  • To highlight advancements in recombinant antibody technology for clinical intrabody applications.

Main Methods:

  • Review of current literature on intrabody technology and protein misfolding diseases.
  • Analysis of intrabody mechanisms, including neutralization and intracellular traffic redirection.
  • Evaluation of recombinant antibody technology for enhanced specificity, stability, and reduced immunogenicity.

Main Results:

  • Intrabodies can specifically recognize and bind to pathological protein conformations.
  • Intrabodies can prevent protein aggregation and redirect intracellular traffic.
  • Recombinant antibody technology has improved intrabody efficacy and clinical applicability.

Conclusions:

  • Intrabodies represent a promising therapeutic approach for conformational diseases.
  • Targeted delivery and enhanced properties of intrabodies offer new treatment avenues.
  • Further development of intrabody technology could lead to effective strategies against debilitating protein misfolding disorders.

More Related Videos

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments12:28

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments

Published on: October 15, 2016

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...